West Pharmaceutical Services completed the sale and transfer of the manufacturing and supply rights for its SmartDose 3.5mL On-Body Delivery System and associated facilities. The transaction closed as planned on July 1, 2026. West will continue to develop and manufacture all other versions of SmartDose, including the SmartDose 10mL On-Body Delivery System and adaptive technology for larger volumes.
West Pharmaceutical Services IncWest completed sale of SmartDose 3.5mL rights, focusing on developing other SmartDose versions including 10mL and larger volumes.